<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang xml:lang>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Introduction</title>
  <style>
html {
line-height: 1.5;
font-family: Georgia, serif;
font-size: 20px;
color: #1a1a1a;
background-color: #fdfdfd;
}
body {
margin: 0 auto;
max-width: 36em;
padding-left: 50px;
padding-right: 50px;
padding-top: 50px;
padding-bottom: 50px;
hyphens: auto;
overflow-wrap: break-word;
text-rendering: optimizeLegibility;
font-kerning: normal;
}
@media (max-width: 600px) {
body {
font-size: 0.9em;
padding: 1em;
}
h1 {
font-size: 1.8em;
}
}
@media print {
body {
background-color: transparent;
color: black;
font-size: 12pt;
}
p, h2, h3 {
orphans: 3;
widows: 3;
}
h2, h3, h4 {
page-break-after: avoid;
}
}
p {
margin: 1em 0;
}
a {
color: #1a1a1a;
}
a:visited {
color: #1a1a1a;
}
img {
max-width: 100%;
}
h1, h2, h3, h4, h5, h6 {
margin-top: 1.4em;
}
h5, h6 {
font-size: 1em;
font-style: italic;
}
h6 {
font-weight: normal;
}
ol, ul {
padding-left: 1.7em;
margin-top: 1em;
}
li > ol, li > ul {
margin-top: 0;
}
blockquote {
margin: 1em 0 1em 1.7em;
padding-left: 1em;
border-left: 2px solid #e6e6e6;
color: #606060;
}
code {
font-family: Menlo, Monaco, 'Lucida Console', Consolas, monospace;
font-size: 85%;
margin: 0;
}
pre {
margin: 1em 0;
overflow: auto;
}
pre code {
padding: 0;
overflow: visible;
overflow-wrap: normal;
}
.sourceCode {
background-color: transparent;
overflow: visible;
}
hr {
background-color: #1a1a1a;
border: none;
height: 1px;
margin: 1em 0;
}
table {
margin: 1em 0;
border-collapse: collapse;
width: 100%;
overflow-x: auto;
display: block;
font-variant-numeric: lining-nums tabular-nums;
}
table caption {
margin-bottom: 0.75em;
}
tbody {
margin-top: 0.5em;
border-top: 1px solid #1a1a1a;
border-bottom: 1px solid #1a1a1a;
}
th {
border-top: 1px solid #1a1a1a;
padding: 0.25em 0.5em 0.25em 0.5em;
}
td {
padding: 0.125em 0.5em 0.25em 0.5em;
}
header {
margin-bottom: 4em;
text-align: center;
}
#TOC li {
list-style: none;
}
#TOC ul {
padding-left: 1.3em;
}
#TOC > ul {
padding-left: 0;
}
#TOC a:not(:hover) {
text-decoration: none;
}
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
width: 0.8em;
margin: 0 0.8em 0.2em -1.6em;
vertical-align: middle;
}
</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<header id="title-block-header">
<h1 class="title">Introduction</h1>
</header>
<p>This thesis will focus on the most common form of prostate cancer,
prostatic adenocarcinoma. For simplicity, we will refer to this type as
just ‘prostate cancer.’ Prostatic cancer is a disease of the epithelial
cells of the prostate. Epithelial cells line our body cavities, our
hollow organs, and glands. They undergo rapid proliferation, primarily
due to damage. This proliferation increases the risk of genetic
mutations, ultimately increasing the risk of a cell uncontrollably
dividing. Together with enabling factors of its tissue environment, this
can give rise to cancer.</p>
<h1 id="the-gleason-grading-system">The Gleason grading system</h1>
<p>In general, the more aggressive cancerous cells are, the less they
will behave and morphologically appear like their original function. The
prostate is a gland that produces prostatic fluid. The fluid is
transported to the urethra by small tubes. These tubes, called prostatic
glands, are lined with epithelium. Low-grade cancer will thus mimic
those gland structures. High-grade prostate cancer loses its structural
morphology, forming sheets of cells or even quasi-randomly dispersed
individual cancerous cells.</p>
<p>American pathologist Donald Floyd Gleason systematically wrote down
the correlation between growth patterns and prognosis in prostate cancer
in the 1960s<span class="citation" data-cites="cite">[@cite]</span>.
Pathologists still use this Gleason grading, albeit several revisions
later<span class="citation" data-cites="cite">[@cite]</span>, to
classify prostate cancer.</p>
<p>[Insert image Gleason grown patterns]</p>
<h1 id="prognostic-biomarkers">Prognostic biomarkers</h1>
<p>The Gleason grading system can be considered a biomarker as it
indicates the prognosis of a patient with prostate cancer<span class="citation" data-cites="chen2011">[@chen2011]</span>. Traditionally
clinicians use nomograms to decide treatment protocols, which combine
the clinical characteristics of the patients with other diagnostic
tests, such as histopathological, radiological assessment, and lab
assessments. The more precise these assessments are, the better we can
tailor the treatment to the specific patient, this is known as
personalized medicine.<span class="citation" data-cites="cite">[@cite]</span></p>
<h3 id="genomic-biomarkers-mutations-prostatedx-etc">Genomic biomarkers
(mutations &amp; prostateDx etc)</h3>
<h3 id="trying-to-leverage-machine-learning-to-make-radiologypathology-reports-more-precise">trying
to leverage machine learning to make radiology/pathology reports more
precise</h3>
<h1 id="introduce-deep-learning">Introduce Deep Learning</h1>
<h3 id="examples-of-pathology-research-wouters-gleason-papers-etc">examples
of pathology research (Wouter’s gleason papers etc)</h3>
<h1 id="introduce-the-dimensionality-problem-of-computation-pathology">Introduce
the dimensionality problem of computation pathology</h1>
<h3 id="introduce-weakly-supervised-methods">Introduce weakly supervised
methods</h3>
<h3 id="conclude-that-they-are-shit.">Conclude that they are shit.</h3>
</body>
</html>
